PL355689A1 - Nowe androgeny - Google Patents

Nowe androgeny

Info

Publication number
PL355689A1
PL355689A1 PL00355689A PL35568900A PL355689A1 PL 355689 A1 PL355689 A1 PL 355689A1 PL 00355689 A PL00355689 A PL 00355689A PL 35568900 A PL35568900 A PL 35568900A PL 355689 A1 PL355689 A1 PL 355689A1
Authority
PL
Poland
Prior art keywords
beta
methylene substituted
androgens
substituted androgens
methylene
Prior art date
Application number
PL00355689A
Other languages
English (en)
Other versions
PL202999B1 (pl
Inventor
Dirk Leysen
Der Louw Jaap Van
Bursi Roberta Buma
Gooyer Marcel Evert De
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL355689A1 publication Critical patent/PL355689A1/pl
Publication of PL202999B1 publication Critical patent/PL202999B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
PL355689A 1999-12-02 2000-11-29 Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów PL202999B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (2)

Publication Number Publication Date
PL355689A1 true PL355689A1 (pl) 2004-05-17
PL202999B1 PL202999B1 (pl) 2009-08-31

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355689A PL202999B1 (pl) 1999-12-02 2000-11-29 Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów

Country Status (27)

Country Link
US (1) US6706700B2 (pl)
EP (1) EP1237904B1 (pl)
JP (1) JP2003515543A (pl)
CN (1) CN1166680C (pl)
AR (1) AR026655A1 (pl)
AT (1) ATE317396T1 (pl)
AU (1) AU778017B2 (pl)
CA (1) CA2390226A1 (pl)
CO (1) CO5251441A1 (pl)
CY (1) CY1106086T1 (pl)
CZ (1) CZ301376B6 (pl)
DE (1) DE60025958T2 (pl)
DK (1) DK1237904T3 (pl)
ES (1) ES2258037T3 (pl)
HK (1) HK1047596B (pl)
HU (1) HUP0203611A3 (pl)
IL (1) IL149424A (pl)
MX (1) MXPA02004939A (pl)
NO (1) NO322422B1 (pl)
NZ (1) NZ518753A (pl)
PE (1) PE20011033A1 (pl)
PL (1) PL202999B1 (pl)
RU (1) RU2242479C2 (pl)
SK (1) SK287095B6 (pl)
TW (1) TWI275593B (pl)
WO (1) WO2001040255A2 (pl)
ZA (1) ZA200203536B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
TWI322813B (en) * 2002-01-21 2010-04-01 Organon Nv Process for the preparation of 7alpha-methylsteroids
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
JP6196625B2 (ja) * 2011-10-07 2017-09-13 エステトラ エス．ペ．エール．エル． エステトロールを製造するための方法
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
ME03728B (me) 2015-06-18 2021-01-20 Estetra Sprl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
RS61777B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetrol
SI3310345T1 (sl) 2015-06-18 2021-05-31 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Also Published As

Publication number Publication date
IL149424A (en) 2007-05-15
CY1106086T1 (el) 2011-06-08
ES2258037T3 (es) 2006-08-16
NZ518753A (en) 2004-05-28
NO20022564L (no) 2002-05-30
NO20022564D0 (no) 2002-05-30
ZA200203536B (en) 2003-08-04
DK1237904T3 (da) 2006-06-06
AU2838301A (en) 2001-06-12
NO322422B1 (no) 2006-10-02
WO2001040255A3 (en) 2001-11-15
HUP0203611A2 (hu) 2003-03-28
AR026655A1 (es) 2003-02-19
CO5251441A1 (es) 2003-02-28
CZ301376B6 (cs) 2010-02-03
CA2390226A1 (en) 2001-06-07
TWI275593B (en) 2007-03-11
AU778017B2 (en) 2004-11-11
EP1237904A2 (en) 2002-09-11
HK1047596A1 (en) 2003-02-28
PL202999B1 (pl) 2009-08-31
WO2001040255A2 (en) 2001-06-07
DE60025958T2 (de) 2006-07-27
EP1237904B1 (en) 2006-02-08
CN1166680C (zh) 2004-09-15
IL149424A0 (en) 2002-11-10
US6706700B2 (en) 2004-03-16
CN1402735A (zh) 2003-03-12
MXPA02004939A (es) 2003-05-23
PE20011033A1 (es) 2001-10-11
JP2003515543A (ja) 2003-05-07
ATE317396T1 (de) 2006-02-15
SK287095B6 (sk) 2009-12-07
RU2242479C2 (ru) 2004-12-20
HK1047596B (zh) 2006-04-21
HUP0203611A3 (en) 2004-07-28
DE60025958D1 (de) 2006-04-20
SK7582002A3 (en) 2002-09-10
CZ20021894A3 (cs) 2002-08-14
US20030100543A1 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
EG24743A (en) Heterocyclic compounds.
EG24814A (en) Novel compounds.
GB0029386D0 (en) Not known at present
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
MXPA02001088A (es) 2-pirazolin-5-onas..
ZA99254B (en) Benzosulfone derivatives.
GB0029389D0 (en) Not known at present
HK1044337A1 (en) Amide compounds.
ZA200201829B (en) New phenylpiperazines.
ZA200108968B (en) New compounds.
GB0014805D0 (en) Glassbreaker (2)
GB0021654D0 (en) Not available at present
HK1047596A1 (en) 14, 15-Beta-methylene substituted androgens
ZA991550B (en) Cyclohexanediole derivatives.
PL353372A1 (pl) Podstawione pochodne heterocyklilo-2H-chromenu
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
HUP0204169A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines an
GB9901323D0 (en) Freeface 1
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
GB9916299D0 (en) Dogex 1
ZA200201714B (en) Novel compound F-15078.
IL165436A0 (en) 7,10-bis-trichlotoacetyl-10 deactylbaccatin III
GB0028459D0 (en) Glor 2

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20101129